Connor, Clark & Lunn Investment Management (CC&L)’s CASTLIGHT HEALTH, INC. CSLT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-104,345
Closed -$161K 1297
2021
Q4
$161K Sell
104,345
-51,655
-33% -$85.2K ﹤0.01% 1002
2021
Q3
$245K Buy
+156,000
New +$306K ﹤0.01% 916
2019
Q3
Sell
-123,575
Closed -$399K 1132
2019
Q2
$399K Buy
123,575
+40,175
+48% +$138K ﹤0.01% 765
2019
Q1
$313K Buy
+83,400
New +$265K ﹤0.01% 744
2017
Q4
Sell
-15,800
Closed -$68K 883
2017
Q3
$68K Sell
15,800
-18,000
-53% -$74.2K ﹤0.01% 792
2017
Q2
$140K Sell
33,800
-5,200
-13% -$20.3K ﹤0.01% 770
2017
Q1
$142K Hold
39,000
﹤0.01% 828
2016
Q4
$193K Sell
39,000
-5,100
-12% -$23.1K ﹤0.01% 795
2016
Q3
$183K Buy
44,100
+23,300
+112% +$95.2K ﹤0.01% 742
2016
Q2
$82K Buy
+20,800
New +$81.6K ﹤0.01% 814

Connor, Clark & Lunn Investment Management (CC&L)'s CSLT Position: Q1 2022 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of CASTLIGHT HEALTH, INC. (CSLT) in Q1 2022, closing a stake of 104,345 shares — an estimated $161K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CSLT in Q2 2016 and held it in 10 quarters. The position peaked at $399K in Q2 2019. 0 funds tracked by Wall St. Rank hold CSLT as of Q1 2022.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining CASTLIGHT HEALTH, INC. position as of Q1 2022 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 104,345 CASTLIGHT HEALTH, INC. shares in Q1 2022, an estimated $161K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CASTLIGHT HEALTH, INC. in Q2 2016 and held it in 10 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s CASTLIGHT HEALTH, INC. position peaked at $399K in Q2 2019.
  • 0 funds tracked by Wall St. Rank held CASTLIGHT HEALTH, INC. as of Q1 2022.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2022, filed 12 May 2022.